Jade Biosciences

JBIONasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$1.065 B

$16.74 -1.18%

Close of 21 Sept 2026

Revenue

—

Not reported

Earnings

-$127.4M

Loss-making

Shares outstanding

63,597,387

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#150Obsidian TherapeuticsOBX$1.07B
#151MoonLake ImmunotherapeuticsMLTX$1.07B
#152Jade BiosciencesJBIO$1.06B
#153Corvus PharmaceuticalsCRVS$1.04B
#154Amphastar PharmaceuticalsAMPH$1.04B

What if Jade Biosciences were worth as much as…

Open the what-if tool →

Gold $30.3T

$476,026.70

Per share 28,436× higher

Bitcoin $1.72T

$27,042.05

Per share 1,615× higher

Nvidia $5.48T

$86,164.83

Per share 5,147× higher

Or at a round number

$2.00B $5.00B $10.0B $20.0B

Where these numbers come from

Share counts and financials for Jade Biosciences are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.